-
公开(公告)号:US09320890B2
公开(公告)日:2016-04-26
申请号:US12941839
申请日:2010-11-08
CPC分类号: A61N1/056 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/222 , A61L2300/608 , A61N1/0568
摘要: The present invention relates to materials having therapeutic compositions releasably contained within the materials. The materials are configured to release therapeutic compositions at a desired rate. The present invention also relates to devices incorporating the materials.
摘要翻译: 本发明涉及具有可释放地包含在材料内的治疗组合物的材料。 这些材料构造成以期望的速率释放治疗组合物。 本发明还涉及包含这些材料的装置。
-
公开(公告)号:US20110268781A1
公开(公告)日:2011-11-03
申请号:US13103885
申请日:2011-05-09
申请人: Robert L. Cleek , Edward H. Cully , Jeffrey B. Duncan , Theresa A. Holland , Thomas R. McDaniel , Christine M. Scotti
发明人: Robert L. Cleek , Edward H. Cully , Jeffrey B. Duncan , Theresa A. Holland , Thomas R. McDaniel , Christine M. Scotti
IPC分类号: A61F2/01 , G06F7/60 , A61P29/00 , A61K31/573 , A61P7/02
CPC分类号: A61L31/10 , A61L29/085 , A61L29/16 , A61L31/16 , A61L2300/222 , A61L2300/608 , A61L2420/08 , A61N1/056 , A61N1/0568
摘要: The present invention relates to materials having therapeutic compositions releasably contained within the materials. The materials are configured to release therapeutic compositions at a desired rate. The present invention also relates to devices incorporating the materials.
-
公开(公告)号:US20110112618A1
公开(公告)日:2011-05-12
申请号:US12941839
申请日:2010-11-08
CPC分类号: A61N1/056 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/222 , A61L2300/608 , A61N1/0568
摘要: The present invention relates to materials having therapeutic compositions releasably contained within the materials. The materials are configured to release therapeutic compositions at a desired rate. The present invention also relates to devices incorporating the materials.
摘要翻译: 本发明涉及具有可释放地包含在材料内的治疗组合物的材料。 这些材料构造成以期望的速率释放治疗组合物。 本发明还涉及包含这些材料的装置。
-
公开(公告)号:US09504771B2
公开(公告)日:2016-11-29
申请号:US13103885
申请日:2011-05-09
申请人: Robert L. Cleek , Edward H. Cully , Jeffrey B. Duncan , Theresa A. Holland , Thomas R. McDaniel , Christine M. Scotti
发明人: Robert L. Cleek , Edward H. Cully , Jeffrey B. Duncan , Theresa A. Holland , Thomas R. McDaniel , Christine M. Scotti
IPC分类号: A61N1/05 , A61K47/30 , A61K47/32 , A61K31/56 , A61F2/01 , A61P29/00 , A61K31/573 , A61P7/02 , A61L29/08 , A61L29/16 , A61L31/10 , A61L31/16
CPC分类号: A61L31/10 , A61L29/085 , A61L29/16 , A61L31/16 , A61L2300/222 , A61L2300/608 , A61L2420/08 , A61N1/056 , A61N1/0568
摘要: The present invention relates to materials having therapeutic compositions releasably contained within the materials. The materials are configured to release therapeutic compositions at a desired rate. The present invention also relates to devices incorporating the materials.
-
公开(公告)号:US20110098797A1
公开(公告)日:2011-04-28
申请号:US12909609
申请日:2010-10-21
IPC分类号: A61K31/573 , A61K9/00 , A61P29/00 , A61N1/05
CPC分类号: A61N1/0568 , A61L29/085 , A61L29/16 , A61L31/10 , A61L31/16 , A61L2300/608
摘要: The present invention relates to materials having therapeutic compositions releasably contained within the materials. The materials are configured to release therapeutic compositions at a desired rate. The present invention also relates to devices incorporating the materials.
-
公开(公告)号:US09005269B2
公开(公告)日:2015-04-14
申请号:US12181197
申请日:2008-07-28
申请人: Joseph R. Armstrong , Paul C. Begovac , Robert L. Cleek , Edward H. Cully , Charles Flynn , Byron K. Hayes , Ryan V. Peterson , Michael J. Vonesh , Charles F. White
发明人: Joseph R. Armstrong , Paul C. Begovac , Robert L. Cleek , Edward H. Cully , Charles Flynn , Byron K. Hayes , Ryan V. Peterson , Michael J. Vonesh , Charles F. White
CPC分类号: A61F2/01 , A61B17/12022 , A61B17/12118 , A61B17/1214 , A61B2017/1205 , A61F2/91 , A61F2/915 , A61F2002/016 , A61F2002/018 , A61F2002/30062 , A61F2002/91508 , A61F2002/91525 , A61F2002/91533 , A61F2002/9155 , A61F2210/0004 , A61F2210/0076 , A61F2220/0016 , A61F2230/005 , A61F2230/0054 , A61F2230/0069 , A61F2230/008 , A61F2250/003 , A61L31/06 , A61L31/148 , C08L67/04
摘要: Bioabsorbable self-expanding medical devices formed of an integral framework with a multiplicity of fenestrations are provided. The framework is continuous, non-filamentous, non-braided, and non-interlaced. The devices includes a non-blended hydrolysable co-polymeric material comprising an amorphous component with a glass transition temperature that is below ambient body temperature and a crystallizable component that possesses a crystalline melting point in excess of ambient body temperature. The devices radially expand from a compressed first diameter to an uncompressed second diameter equal to or greater than 1.5 times the first diameter within two minutes in an aqueous medium at 37° C. following release of a compressive force placed on the devices. Additionally, the medical device does not change axial length significantly as the radial dimensions of the devices are changed. Further, the medical devices may be constructed of different bioabsorbable polymers, polymer ratios, and/or different geometries and portions may bioabsorb at different rates.
摘要翻译: 提供由具有多个开窗的整体框架形成的生物可吸收的自扩张医疗装置。 框架是连续的,非丝状的,非编织的和非隔行的。 该装置包括非共混的可水解共聚物材料,其包含玻璃化转变温度低于环境体温的非晶组分和具有超过环境体温的结晶熔点的可结晶组分。 在放置在装置上的压缩力释放之后,装置在37℃下在含水介质中在两分钟内从压缩的第一直径径向膨胀至等于或大于第一直径的1.5倍的未压缩的第二直径。 此外,随着装置的径向尺寸改变,医疗装置不会显着改变轴向长度。 此外,医疗装置可以由不同的生物可吸收聚合物,聚合物比率和/或不同的几何形状构成,并且部分可以以不同的速率生物吸收。
-
公开(公告)号:US20120065721A1
公开(公告)日:2012-03-15
申请号:US13282892
申请日:2011-10-27
IPC分类号: A61F2/82
CPC分类号: A61L31/10 , A61L27/34 , C08L101/04
摘要: A medical device provided with at least a partial surface coating of a thermoplastic copolymer of tetrafluoroethylene and perfluoroalkylvinylether that is free of cross-linking monomers and curing agents. The fluoropolymer coating is preferably an amorphous thermoplastic, is highly inert and biocompatible, has elastomeric characteristics that provide desirable mechanical properties such as good flexibility and durability. These characteristics allow the coating to be considered “functionally transparent” because it withstands mechanical deformations required for the assembly, deployment, expansion, and placement of medical devices, without any adverse effect on the mechanical and biological functionality of the coated device. Further, its inertness, derived from the perfluorocarbon structure, contributes to its functionally transparent nature. The coating can be provided with various liquid or solid additives, can be loaded with large quantities of additives including a wide range of therapeutic agents, and has excellent drug elution characteristics when elutable additives are used.
摘要翻译: 一种医疗装置,其具有不含交联单体和固化剂的四氟乙烯和全氟烷基乙烯基醚的热塑性共聚物的至少部分表面涂层。 含氟聚合物涂层优选为无定形热塑性塑料,具有高度惰性和生物相容性,具有提供所需机械性能(例如良好的柔韧性和耐久性)的弹性体特性。 这些特性使得涂层被认为是“功能上透明的”,因为它可以承受医疗装置的组装,展开,膨胀和放置所需的机械变形,而不会对涂覆装置的机械和生物功能产生任何不利影响。 此外,其衍生自全氟化碳结构的惰性有助于其功能上的透明性。 该涂层可以提供各种液体或固体添加剂,可以加载大量的添加剂,包括广泛的治疗剂,并且当使用可洗脱添加剂时具有优异的药物洗脱特性。
-
公开(公告)号:US08048440B2
公开(公告)日:2011-11-01
申请号:US11378401
申请日:2006-03-16
IPC分类号: A61F2/82
CPC分类号: A61L31/10 , A61L27/34 , C08L101/04
摘要: A medical device provided with at least a partial surface coating of a thermoplastic copolymer of tetrafluoroethylene and perfluoroalkylvinylether that is free of cross-linking monomers and curing agents. The fluoropolymer coating is preferably an amorphous thermoplastic, is highly inert and biocompatible, has elastomeric characteristics that provide desirable mechanical properties such as good flexibility and durability. These characteristics allow the coating to be considered “functionally transparent” because it withstands mechanical deformations required for the assembly, deployment, expansion, and placement of medical devices, without any adverse effect on the mechanical and biological functionality of the coated device. Further, its inertness, derived from the perfluorocarbon structure, contributes to its functionally transparent nature. The coating can be provided with various liquid or solid additives, can be loaded with large quantities of additives including a wide range of therapeutic agents, and has excellent drug elution characteristics when elutable additives are used. The desirable mechanical characteristics are surprising given the absence of cross-linking monomers and curing agents that would otherwise render such materials inadequately biocompatible. The perfluoroalkylvinylether may be perfluoromethylvinylether, perfluoroethylvinylether or perfluoropropylvinylether.
摘要翻译: 一种医疗装置,其具有不含交联单体和固化剂的四氟乙烯和全氟烷基乙烯基醚的热塑性共聚物的至少部分表面涂层。 含氟聚合物涂层优选为无定形热塑性塑料,具有高度惰性和生物相容性,具有提供所需机械性能(例如良好的柔韧性和耐久性)的弹性体特性。 这些特性使得涂层被认为是“功能上透明的”,因为它可以承受医疗装置的组装,展开,膨胀和放置所需的机械变形,而不会对涂覆装置的机械和生物功能产生任何不利影响。 此外,其衍生自全氟化碳结构的惰性有助于其功能上的透明性。 该涂层可以提供各种液体或固体添加剂,可以加载大量的添加剂,包括广泛的治疗剂,并且当使用可洗脱添加剂时具有优异的药物洗脱特性。 鉴于不存在交联单体和固化剂,否则将使得这些材料生物相容性不足,理想的机械特性令人惊奇。 全氟烷基乙烯基醚可以是全氟甲基乙烯基醚,全氟乙基乙烯基醚或全氟丙基乙烯基醚。
-
公开(公告)号:US08609125B2
公开(公告)日:2013-12-17
申请号:US13282892
申请日:2011-10-27
IPC分类号: A61F2/02
CPC分类号: A61L31/10 , A61L27/34 , C08L101/04
摘要: A medical device provided with at least a partial surface coating of a thermoplastic copolymer of tetrafluoroethylene and perfluoroalkylvinylether that is free of cross-linking monomers and curing agents. The fluoropolymer coating is preferably an amorphous thermoplastic, is highly inert and biocompatible, has elastomeric characteristics that provide desirable mechanical properties such as good flexibility and durability. These characteristics allow the coating to be considered “functionally transparent” because it withstands mechanical deformations required for the assembly, deployment, expansion, and placement of medical devices, without any adverse effect on the mechanical and biological functionality of the coated device. Further, its inertness, derived from the perfluorocarbon structure, contributes to its functionally transparent nature. The coating can be provided with various liquid or solid additives, can be loaded with large quantities of additives including a wide range of therapeutic agents, and has excellent drug elution characteristics when elutable additives are used.
摘要翻译: 一种医疗装置,其具有不含交联单体和固化剂的四氟乙烯和全氟烷基乙烯基醚的热塑性共聚物的至少部分表面涂层。 含氟聚合物涂层优选为无定形热塑性塑料,具有高度惰性和生物相容性,具有提供所需机械性能(例如良好的柔韧性和耐久性)的弹性体特性。 这些特性使得涂层被认为是“功能上透明的”,因为它可以承受医疗装置的组装,展开,膨胀和放置所需的机械变形,而不会对涂覆装置的机械和生物功能产生任何不利影响。 此外,其衍生自全氟化碳结构的惰性有助于其功能上的透明性。 该涂层可以提供各种液体或固体添加剂,可以加载大量的添加剂,包括广泛的治疗剂,并且当使用可洗脱添加剂时具有优异的药物洗脱特性。
-
公开(公告)号:US20130035665A1
公开(公告)日:2013-02-07
申请号:US13565707
申请日:2012-08-02
申请人: Chaokang Chu , Robert L. Cleek , Edward H. Cully , Jeffrey Duncan , Krzysztof R. Pietrzak , Edward Emil Shaw , Michael J. Vonesh , Eric H. Zacharias
发明人: Chaokang Chu , Robert L. Cleek , Edward H. Cully , Jeffrey Duncan , Krzysztof R. Pietrzak , Edward Emil Shaw , Michael J. Vonesh , Eric H. Zacharias
CPC分类号: A61B17/12181 , A61B17/12118 , A61B17/12145 , A61B17/1215 , A61B17/12163 , A61B17/1219 , A61B2017/00893 , A61B2017/00942 , A61B2017/1205 , A61B2017/12054 , A61B2050/3008 , A61B2090/0807 , A61L31/00 , A61L31/14 , A61L2430/36
摘要: A method of occluding includes imbibing a porous elongate element comprised of ePTFE with a calcium-containing solution. The method also includes delivering, via a delivery catheter, the calcium-imbibed porous elongate element to a target occlusion site. The method further includes administering, after the calcium-imbibed porous elongate element has been completely delivered to the target occlusion site and resides entirely within a volume defined by the target occlusion site, an alginate-containing solution to the target occlusion site.
摘要翻译: 封闭的方法包括用含钙溶液吸收由ePTFE组成的多孔细长元件。 该方法还包括通过递送导管将钙吸收的多孔细长元件递送到目标闭塞部位。 该方法还包括在钙吸收的多孔细长元件已经完全递送到目标闭塞部位之后并且完全位于由目标闭塞部位限定的体积内的情况下,将含藻酸盐的溶液施用于靶闭塞部位。
-
-
-
-
-
-
-
-
-